ALSEN — Sensorion SA Share Price
- €62.86m
- -€1.79m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.87 | ||
Price to Tang. Book | 0.88 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -37.56% | ||
Return on Equity | -49.28% | ||
Operating Margin | n/a |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | €m | n/a | n/a | n/a | n/a | n/a | 15.21 | 17.6 | n/a |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Sensorion SA is a France-based company principally engaged in the biopharmaceutical sector. The Company is principally active in the development of targeted therapeutic solutions to treat inner ear diseases. The Company develops also drug treatments, from molecular biology all the way to animal pharmacology, toxicology, and clinical research and therapeutic solutions to treat vestibular deficits. Sensorion SA is a spin-off of the research team Pathophysiology and Therapy of Vestibular Deficits in Montpellier Neuroscience Institute.
Directors
- Edwin Moses CHM (67)
- Nawal Ouzren CEO
- Otmane Boussif CTO
- Geraldine Honnet OTH
- Khalil Barrage DRC (56)
- Chahra Louafi DRC
- Julien Miara DRC
- Cedric Moreau DRC
- Eric de La Fortelle IND
- John Furey IND (56)
- Aniz Girach IND
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 25th, 2009
- Public Since
- April 21st, 2015
- No. of Employees
- 63
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
Euronext - Paris
- Shares in Issue
- 300,501,226

- Address
- 375, rue du Professeur Joseph Blayac, MONTPELLIER, 34080
- Web
- https://www.sensorion-pharma.com/
- Phone
- +33 467207730
- Contact
- Catherine Leveau
- Auditors
- Ernst & Young Audit
Upcoming Events for ALSEN
Sensorion SA Extraordinary Shareholders Meeting
Sensorion SA Annual Shareholders Meeting
Half Year 2025 Sensorion SA Earnings Release
Similar to ALSEN
Abionyx Pharma SA
Euronext - Paris
Abivax SA
Euronext - Paris
Adocia SA
Euronext - Paris
Biophytis SA
Euronext - Paris
Cellectis SA
Euronext - Paris
FAQ
As of Today at 23:09 UTC, shares in Sensorion SA are trading at €0.21. This share price information is delayed by 15 minutes.
Shares in Sensorion SA last closed at €0.21 and the price had moved by -70.54% over the past 365 days. In terms of relative price strength the Sensorion SA share price has underperformed the FTSE Global All Cap Index by -71.27% over the past year.
The overall consensus recommendation for Sensorion SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreSensorion SA does not currently pay a dividend.
Sensorion SA does not currently pay a dividend.
Sensorion SA does not currently pay a dividend.
To buy shares in Sensorion SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €0.21, shares in Sensorion SA had a market capitalisation of €62.86m.
Here are the trading details for Sensorion SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: ALSEN
Based on an overall assessment of its quality, value and momentum Sensorion SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Sensorion SA is €2.20. That is 951.63% above the last closing price of €0.21.
Analysts covering Sensorion SA currently have a consensus Earnings Per Share (EPS) forecast of -€0.08 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sensorion SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -71.54%.
As of the last closing price of €0.21, shares in Sensorion SA were trading -67.33% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Sensorion SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €0.21.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Sensorion SA's management team is headed by:
- Edwin Moses - CHM
- Nawal Ouzren - CEO
- Otmane Boussif - CTO
- Geraldine Honnet - OTH
- Khalil Barrage - DRC
- Chahra Louafi - DRC
- Julien Miara - DRC
- Cedric Moreau - DRC
- Eric de La Fortelle - IND
- John Furey - IND
- Aniz Girach - IND